October 28, 2026 12:19 PM
Anthropic uses Claude to generate 35,000 antibody designs for food allergy treatment, targets faster drug development
Artificial intelligence company Anthropic said its Claude model generated around 35,000 antibody designs in about a month for a potential food allergy treatment, as it expands efforts to use AI across drug discovery, manufacturing and clinical development. In an update on its life sciences research, Anthropic said its work with biotechnology company Divergence Labs produced early results for a proposed treatment designed to remove immunoglobulin E (IgE), a molecule involved in allergic reaction...